President Donald Trump becomes Dr. Jay Bhattacharya, the next director of the National Institutes of Health (NIH), and most of his confirmation hearings defended the president’s decision to defend 15% of the decision on Wednesday Indirect research cost limit Dispelled by NIH.
Bhattacharya, a professor of medicine at Stanford University and a senior fellow at the University’s Institute of Economic Policy, would not make it clear that he disagrees with the cuts, or, if confirmed, he would step in to stop them. Instead, he said he would “comply with the law” while also investigating the impact of the cuts and ensuring that every NIH researcher is working to improve American health outcomes and have the resources needed to get the job done.
Bhattacharya also proposes a new, fragmented future vision NIH research He said it will aim to embrace dissenting ideas and transparency while focusing on research topics that have the best chance to benefit American health outcomes directly. Bhattacharya added that he wanted to get rid of the research portfolio of other “reckless” efforts, which he said did not do all that to do to benefit directly from health outcomes.
HHS Secretary RFK Jr. Measles prevention and protection are crucial: Contributors
“Since trust in public health institutions has collapsed since the pandemic, there is a lot of distrust of where the money goes,” Bhattacharya said. “I think the transparency about the overhead costs is absolutely worth it. This is something that universities can solve by working together to make sure that the money is clear.”
Earlier this month, the Trump administration announced it would cut billions of dollars in overhead costs, linked to federally funded research grants, which are provided to various agencies as part of a broader action by the Trump administration to cut wasteful spending. (U.S. Senate Health, Education, Labor, and Pension Committee.)
Democratic sensitivity in Maryland Angela Alsobrooks and Ed Markey of Massachusetts have imposed urgent research on Bhattacharya to study health issues that affect minorities – Democrats are worried on the NIH that Trump has been marred by Trump’s opposition to the left’s view on diversity, equity and equity and inclusion (DEI).
“The health needs of minorities in this country are crucial to me … I want to make sure that the NIH research does meet those health needs and that I don’t see anything in the president’s orders that is actually the opposite of what it is,” Bhattacharya said. “What did I hear from it [Secretary Robert F. Kennedy Jr.] The president is “make us healthy,” which means all Americans. ”
Millions of dollars in biden-biden-era covid-19 vax project stopped by Trump’s HHS
When Alsobrooks cites a project in Bhattacharya that involves directing “diversified” professionals, he said his understanding of the project means guiding researchers with various ideas rather than diverse skin tones.
“I think fundamentally, what’s important is: Does scientists have an idea to advance their field of science?” Bhattacharya replied. “They had an idea and finally solved it Health needs American? ”
Bhattacharya acknowledges that “identification” of health differences among minorities is important, but emphasizes the need for research that drives meaningful results.
Sen. Angela Alsobrooks, a Democratic Maryland, is the promise of helping the committee to question Bhattacharya’s commitment and to restore research that is inconsistent with his anti-DEI agenda. (Andrew Harnik/Getty Images)
Bhattacharya also raised similar questions to Markey, who argued that Trump is using ideological flashpoints to save lives “slowly” research.
Trump administrators faced “Democratic hysteria” and listed who were laid off on HHS.
“Senator, I don’t agree with you President Trump be opposed to [speeding up research]. In fact, on the contrary, he is very much in favor of making America healthy,” Batacaria told Markey. “I don’t think ideology should be sure whether it is being studied. ”
Sen. Ed Markey, Democrat of Massachusetts, joined the airport service workers and union leaders on Capitol Hill, urging Congress to pass a pro-union policy in 2023. (Getty Images of Leigh Vogel/SEIU)
In addition to addressing numerous Democratic questions about Trump’s cuts in funding, Bhattacharya outlined his plans to reform the NIH’s research portfolio at Wednesday’s confirmation hearing.
Trump’s NIH nominee said he hopes to focus on cutting-edge research and other “big ideas” rather than continuing to invest all federal government funds in research that does not involve equally ambitious goals. He also briefly talked about increasing the frequency of “validation studies” and increasing the number of NIH applications funded for young researchers.
Worry Republicans Included at the hearing whether Bhattacharya will continue to support the link between research investigation Vaccines and autism, R-La’s Senator Bill Cassidy said it has proven over and over again that there is no connection and whether he allows continued use of miscarriage fetal tissue in NIH-funded studies.
Despite Trump’s NIH research funding cap
When receiving a NIH research grant, in addition to the allocated research funds,,,,, Go to the facilities of the housing to pay for the “overhead”. (Fox News)
Click here to get the Fox News app
Bhattacharya agrees with Cassidy that the link between autism and vaccines is obvious – no one. However, he admits that others may not agree with him. In line with his commitment to accepting opposition ideas and promoting freedom of speech in medical research, he suggested debugging research can help the public more clearly understand that no connection exists.
Question about stopping use Aborted fetal tissue, During Trump’s first term, he banned it, and Batacharia said he would follow the president’s leadership on the issue.
